Barbara Aldana Blanco1, Michael Poulson1, Kelly M Kenzik1,2, David B McAneny1, Jennifer F Tseng1, Teviah E Sachs3. 1. Department of Surgery, Surgical Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA. 2. Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA. 3. Department of Surgery, Surgical Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA. Teviah.Sachs@bmc.org.
Abstract
BACKGROUND: Disparities in pancreatic cancer outcomes between black and white patients are well documented. This study aimed to use a more novel index to examine the impact of racial segregation on the diagnosis, management, and outcomes of pancreatic cancer in black patients compared with white patients. METHODS: Black and white adults with pancreatic cancer in urban counties were identified using data from the 2018 submission of the Surveillance, Epidemiology and End Results (SEER) Program and the 2010 Census. The racial index of dissimilarity (IoD), a validated proxy of racial segregation, was used to assess the evenness with which whites and blacks are distributed across census tracts in each county. Multivariate Poisson regression was performed, and stepwise models were constructed for each of the outcomes. Overall survival was studied using the Kaplan-Meier method. RESULTS: The study enrolled 60,172 adults with a diagnosis of pancreatic cancer between 2005 and 2015. Overall, the black patients (13.8% of the cohort) lived in more segregated areas (IoD, 0.67 vs 0.61; p < 0.05). They were less likely to undergo surgery for localized disease (relative risk [RR], 0.80; 95% confidence interval [CI], 0.76-0.83) and more frequently had a diagnosis of advanced-stage disease (RR, 1.09; 95% CI, 1.01-1.19) with increasing segregation. They also had shorter survival times (9.8 vs 11.4 months; p < 0.05). CONCLUSIONS: Disparities in advanced-stage disease at diagnosis, surgery for localized disease, and overall survival are directly related to the degree of residential segregation, a proxy for structural racism. In searching for solutions to this problem, it is important to account for the historical marginalization of black Americans.
BACKGROUND: Disparities in pancreatic cancer outcomes between black and white patients are well documented. This study aimed to use a more novel index to examine the impact of racial segregation on the diagnosis, management, and outcomes of pancreatic cancer in black patients compared with white patients. METHODS: Black and white adults with pancreatic cancer in urban counties were identified using data from the 2018 submission of the Surveillance, Epidemiology and End Results (SEER) Program and the 2010 Census. The racial index of dissimilarity (IoD), a validated proxy of racial segregation, was used to assess the evenness with which whites and blacks are distributed across census tracts in each county. Multivariate Poisson regression was performed, and stepwise models were constructed for each of the outcomes. Overall survival was studied using the Kaplan-Meier method. RESULTS: The study enrolled 60,172 adults with a diagnosis of pancreatic cancer between 2005 and 2015. Overall, the black patients (13.8% of the cohort) lived in more segregated areas (IoD, 0.67 vs 0.61; p < 0.05). They were less likely to undergo surgery for localized disease (relative risk [RR], 0.80; 95% confidence interval [CI], 0.76-0.83) and more frequently had a diagnosis of advanced-stage disease (RR, 1.09; 95% CI, 1.01-1.19) with increasing segregation. They also had shorter survival times (9.8 vs 11.4 months; p < 0.05). CONCLUSIONS: Disparities in advanced-stage disease at diagnosis, surgery for localized disease, and overall survival are directly related to the degree of residential segregation, a proxy for structural racism. In searching for solutions to this problem, it is important to account for the historical marginalization of black Americans.
Authors: Kiarri N Kershaw; Ana V Diez Roux; Sarah A Burgard; Lynda D Lisabeth; Mahasin S Mujahid; Amy J Schulz Journal: Am J Epidemiol Date: 2011-06-22 Impact factor: 4.897
Authors: Omeed Moaven; Joshua S Richman; Sushanth Reddy; Thomas Wang; Martin J Heslin; Carlo M Contreras Journal: Am J Surg Date: 2018-12-10 Impact factor: 2.565
Authors: Melissa M Murphy; Jessica P Simons; Sing Chau Ng; Theodore P McDade; Jillian K Smith; Shimul A Shah; Zheng Zhou; Craig C Earle; Jennifer F Tseng Journal: Ann Surg Oncol Date: 2009-08-11 Impact factor: 5.344
Authors: Jennifer S Haas; Craig C Earle; John E Orav; Phyllis Brawarsky; Marie Keohane; Bridget A Neville; David R Williams Journal: Cancer Date: 2008-10-15 Impact factor: 6.860
Authors: Jennifer S Haas; Craig C Earle; John E Orav; Phyllis Brawarsky; Bridget A Neville; David R Williams Journal: J Gen Intern Med Date: 2008-03-13 Impact factor: 5.128
Authors: Anasooya Abraham; Waddah B Al-Refaie; Helen M Parsons; Vikas Dudeja; Selwyn M Vickers; Elizabeth B Habermann Journal: Ann Surg Oncol Date: 2013-04-12 Impact factor: 5.344
Authors: Ryan Nipp; Angela C Tramontano; Chung Yin Kong; Pari Pandharipande; Emily C Dowling; Deborah Schrag; Chin Hur Journal: Cancer Med Date: 2018-01-11 Impact factor: 4.452
Authors: Jennifer B Permuth; Ashley Clark Daly; Daniel Jeong; Jung W Choi; Miles E Cameron; Dung-Tsa Chen; Jamie K Teer; Tracey E Barnett; Jiannong Li; Benjamin D Powers; Nagalakshmi B Kumar; Thomas J George; Karla N Ali; Tri Huynh; Shraddha Vyas; Clement K Gwede; Vani N Simmons; Pamela J Hodul; Estrella M Carballido; Andrew R Judge; Jason B Fleming; Nipun Merchant; Jose G Trevino Journal: Cancer Med Date: 2019-05-09 Impact factor: 4.452
Authors: Jonathan Pastrana Del Valle; Nathanael R Fillmore; George Molina; Mark Fairweather; Jiping Wang; Thomas E Clancy; Stanley W Ashley; Richard D Urman; Edward E Whang; Jason S Gold Journal: Ann Surg Oncol Date: 2022-01-10 Impact factor: 5.344
Authors: Megan Hansen; Nadine M Hamieh; Sarah C Markt; Jane B Vaselkiv; Claire H Pernar; Amparo G Gonzalez-Feliciano; Samuel Peisch; Ilkania M Chowdhury-Paulino; Emily M Rencsok; Timothy R Rebbeck; Elizabeth A Platz; Edward L Giovannucci; Kathryn M Wilson; Lorelei A Mucci Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-05-04 Impact factor: 4.090
Authors: Belinda L Needham; Talha Ali; Kristi L Allgood; Annie Ro; Jana L Hirschtick; Nancy L Fleischer Journal: J Racial Ethn Health Disparities Date: 2022-08-22